PTHS — Pelthos Therapeutics Inc.
—
NYSE ·
Health Care ·
Biotechnology ·
CIK 1919246 ·
Last close
$22.19
Market Cap
$84.95M
52W High
$37.50
52W Low
$18.19
ADV30
42,330
Next earnings
2026-11-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 15,603,000 | 2,774,000 | -17,323,000 | -23,417,000 | 137,356,000 | 24,192,000 | 138,857,000 |
| Mar 2026 | 10,906,000 | 5,594,000 | -13,088,000 | -10,238,000 | 145,378,000 | 31,976,000 | 110,276,000 |
| Dec 2025 | 9,389,000 | 6,126,000 | -12,003,000 | -21,664,000 | 130,397,000 | 17,973,000 | 91,516,000 |
| Sep 2025 | 7,406,000 | 3,845,000 | -15,362,000 | -16,238,000 | 126,433,000 | 14,203,000 | 68,180,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-35,084,000
Investing CF
$-194,000
Financing CF
$72,609,000
CapEx
$-194,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-20.64
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-75,032,000
Inventory
$23,418,000
Receivables
$11,700,000
ST Investments
—
EBIT TTM
$-53,744,423
Pretax Income TTM
$-58,975,939
Interest Exp TTM
$5,231,516
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$43,304,000
EBITDA
—
Free Cash Flow
$-36,573,780
Enterprise Value
$132,760,472
Total Cash
$24,192,000
Total Debt
$73,109,000
Shares Out
3,828,469
Trailing EPS
$-28.63
Book Value
$-0.40
ROE
-333.8%
ROA
-50.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 16,795,000 | -32,430,000 | -43,319,000 | 130,397,000 | 91,516,000 | 38,881,000 | -22,590,000 |
| Dec 2024 | 0 | -7,571,000 | -7,955,000 | 1,369,000 | 4,083,000 | -2,714,000 | -5,792,000 |
| Dec 2023 | 0 | -6,862,284 | -7,380,793 | 96,391 | 6,540,943 | -6,444,552 | -981,031 |
| Dec 2022 | 0 | -2,318,159 | -2,458,589 | 55,074 | 3,761,611 | -3,706,537 | -1,567,149 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-1,968,000
OpCashFlow TTM
$0
Assets (Latest)
$130,397,000
Forward EPS
$-5.68
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ATRA | Atara Biotherapeutics, Inc. | $88.43M | $8.81 | — |
| CGTX | COGNITION THERAPEUTICS INC | $89.10M | $0.94 | — |
| CRDF | Cardiff Oncology, Inc. | $96.47M | $1.24 | — |
| BSEM | BioStem Technologies, Inc. | $73.82M | $4.14 | — |
| OKYO | OKYO Pharma Ltd | $72.42M | $1.38 | — |
News headlines (Yahoo Finance, 1h cache)
Pelthos (PTHS) Q2 2026 Earnings Call Transcript
2026-08-20 13:04 · Yahoo
Pelthos Therapeutics Inc (PTHS) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as ...
2026-08-13 23:06 · Yahoo
Pelthos Therapeutics Inc. (PTHS) Reports Q2 Loss, Lags Revenue Estimates
2026-08-13 12:25 · Yahoo
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
2026-08-13 11:10 · Yahoo
Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026
2026-08-03 12:00 · Yahoo
Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
2026-06-30 20:15 · Yahoo
Pelthos Therapeutics Q2 Earnings Call Highlights
2026-08-14 08:04 · Yahoo
Pelthos Therapeutics Inc. Q2 2026 Earnings Call Summary
2026-08-13 21:05 · Yahoo
This Biotech Dealmaker — Tied To Merck, Travere — Is In A Profit-Taking Zone
2026-08-06 20:08 · Yahoo
Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
2026-07-24 21:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.